Episode Synopsis "Trials and PIs with Dr Michael Gibson #12: Double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD with Dr Shinya Goto"

What you need to know about today’s top cardiovascular trials in five minutes flat. Join Dr C Michael Gibson for brief interviews with the principal investigators

Listen "Trials and PIs with Dr Michael Gibson #12: Double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD with Dr Shinya Goto"

More episodes of the podcast Trials and PIs with Dr Michael Gibson

• Trials and PIs with Dr Michael Gibson #17: DANPACE with Dr Jens C Nielsen
• Trials and PIs with Dr Michael Gibson #16: ANTIPAF with Dr Andreas Goette
• Trials and PIs with Dr Michael Gibson #15: AVERROES with Dr Stuart J Connolly
• Trials and PIs with Dr Michael Gibson #14: FUTURA OASIS 8 with Dr Sanjit Jolly
• Trials and PIs with Dr Michael Gibson #13: RESPONSE with Dr Ron J Peters
• Trials and PIs with Dr Michael Gibson #12: Double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD with Dr Shinya Goto
• Trials and PIs with Dr Michael Gibson #11: ART with Dr David P Taggart
• Trials and PIs with Dr Michael Gibson #10: HEBE III with Dr A Voors
• Trials and PIs with Dr Michael Gibson #9: PCI: State of the art with Dr Sunil Rao
• Trials and PIs with Dr Michael Gibson #8: Bleeding Academic Research Consortium (BARC) with Dr Sunil Rao
• Trials and PIs with Dr Michael Gibson #7: INNOVATE PCI with Dr Sunil Rao
• Trials and PIs with Dr Michael Gibson #6: ISAR REACT 3A with Dr Gilles Montalescot
• Trials and PIs with Dr Michael Gibson #5: Meta-analysis of new thienopyridines with Dr Gilles Montalescot
• Trials and PIs with Dr Michael Gibson #4: ATOLL with Dr Gilles Montalescot
• Trials and PIs with Dr Michael Gibson #3: ALPHA OMEGA with Dr Daan Kromhout
• Trials and PIs with Dr Michael Gibson #2: PEARL HF with Dr Bertram Pitt
• Trials and PIs with Dr Michael Gibson #1: Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19 2 loss of function polymorphism with Dr Laurent Bonell